← Leaderboards
David L Lampi Hermanson
B-Mogen Biotechnologies, Inc.
$1,624,672
Attributed
$1,624,672
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–20$2M$1.5M$1M$500K$0
'18
'19
'20
Funding mix
By agency
NIH$1,624,672 · 1
By mechanism
R44$1,624,672 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Environment”
- Valerie Koch · University Corporation For Atmospheric Res$244,517,972
- Scott Topper · Broad Institute, Inc.$77,958,806
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,503,514
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Prasant Mohapatra · University Of California At Davis$40,097,014
Research focus
EnvironmentFda ApprovedEnsureAcute Lymphocytic LeukemiaCancer ImmunotherapyEffectivenessBiotechnologyEngineeringCd19 GeneCd3 AntigensCell KillingCellsCancer PatientBaseCancer TherapyChimeric Antigen ReceptorCarrying CapacitiesClinical TrialsCommunicable DiseasesCostCost EffectiveCyclic GmpDna DeliveryGene Delivery
Grant awards (3)
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy$314,418
R44 · FY2020 · CA · contact PI
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy$1,091,666
R44 · FY2019 · CA · contact PI
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy$218,588
R44 · FY2018 · CA · contact PI